CN Patent

CN117561244A — 异吲哚啉酮类化合物及其用途

Assigned to Hangzhou Gebo Biopharmaceutical Co ltd · Expires 2024-02-13 · 2y expired

What this patent protects

本申请属于医学领域。本公开提供了如结构式(I)所示的异吲哚酮化合物或其药学上可接受的盐，以及其在治疗增殖性疾病中的用途。还提供了一种药物组合物，所述药物组合物包含所述化合物或其盐，和药学上可接受的载体。

USPTO Abstract

本申请属于医学领域。本公开提供了如结构式(I)所示的异吲哚酮化合物或其药学上可接受的盐，以及其在治疗增殖性疾病中的用途。还提供了一种药物组合物，所述药物组合物包含所述化合物或其盐，和药学上可接受的载体。

Drugs covered by this patent

Patent Metadata

Patent number
CN117561244A
Jurisdiction
CN
Classification
—
Expires
2024-02-13
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Gebo Biopharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.